Legal Disclaimer

The content and information provided within this site is for informational and educational purposes only. Consult a doctor before pursuing any form of therapy, including Hyperbaric Oxygen Therapy. The Information provided within this site is not to be considered Medical Advice. In Full Support of the F.D.A., Hyperbaric Oxygen Therapy is considered Investigational, Experimental, or Off Label.

Please consult with your Treating Medical Physician

Effects of Hyperbaric Oxygen in Fungal infections
“Candida Albicans”

The growth of Candida Albicans in vitro is inhibited by prolonged exposure to Hyperbaric Oxygen. At 2.5 ata. This protocol was chosen to approximate the levels of oxygen found in tissues found in the tissues of patients treated with HBOT. Prolonged exposure to HBOT between 2.5 and 3 ata is funcidal for C. albican and several other Candida. There is strong evidence that Pneumocystis carinii is a fungus. P. Carinii has low levels of antioxidant enzymes and is very susceptible to hyperoxia. A 10-minute exposure to hyperbaric in vitro appears to be lethal for this microorganism.

HBOT appears to represent means for treatment of this fungus where standard anti fungal agents have failed.

“The Text Book Of Hyperbaric Medicine, Vol. 3
K.K. Jain MD

Printed with Permission